Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression
- PMID: 33834417
- DOI: 10.1007/978-981-33-6044-0_27
Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression
Abstract
Depression contributes greatly to global disability and is a leading cause of suicide. It has multiple etiologies and therefore response to treatment can vary significantly. By applying the concepts of personalized medicine, precision psychiatry attempts to optimize psychiatric patient care by better predicting which individuals will develop an illness, by giving a more accurate biologically based diagnosis, and by utilizing more effective treatments based on an individual's biological characteristics (biomarkers). In this chapter, we discuss the basic principles underlying the role of biomarkers in psychiatric pathology and then explore multiple biomarkers that are specific to depression. These include endophenotypes, gene variants/polymorphisms, epigenetic factors such as methylation, biochemical measures, circadian rhythm dysregulation, and neuroimaging findings. We also examine the role of early childhood trauma in the development of, and treatment response to, depression. In addition, we review how new developments in technology may play a greater role in the determination of new biomarkers for depression.
Keywords: Biomarkers; Depression; Endophenotypes; Epigenetics; Genetics; Neuroimaging; Precision psychiatry.
Similar articles
-
Biomarker-Guided Tailored Therapy.Adv Exp Med Biol. 2019;1192:199-224. doi: 10.1007/978-981-32-9721-0_10. Adv Exp Med Biol. 2019. PMID: 31705496
-
Personalized medicine in psychiatry: problems and promises.BMC Med. 2013 May 16;11:132. doi: 10.1186/1741-7015-11-132. BMC Med. 2013. PMID: 23680237 Free PMC article. Review.
-
Prediction of response to drug therapy in psychiatric disorders.Open Biol. 2018 May;8(5):180031. doi: 10.1098/rsob.180031. Open Biol. 2018. PMID: 29794033 Free PMC article. Review.
-
Biomarker-Guided Tailored Therapy in Major Depression.Adv Exp Med Biol. 2024;1456:379-400. doi: 10.1007/978-981-97-4402-2_19. Adv Exp Med Biol. 2024. PMID: 39261439 Review.
-
Precision psychiatry - a feasible possibility?Cas Lek Cesk. 2019 Winter;158(7-8):328-331. Cas Lek Cesk. 2019. PMID: 31996003 English.
Cited by
-
Alterations in electroencephalographic functional connectivity in individuals with major depressive disorder: a resting-state electroencephalogram study.Front Neurosci. 2024 Jul 10;18:1412591. doi: 10.3389/fnins.2024.1412591. eCollection 2024. Front Neurosci. 2024. PMID: 39055996 Free PMC article.
-
Visualization of estimated prevalence of CES-D positivity accounting for background factors and AIS scores.Sci Rep. 2022 Oct 21;12(1):17656. doi: 10.1038/s41598-022-22266-1. Sci Rep. 2022. PMID: 36271231 Free PMC article.
-
Major Depressive Disorder and Chronic Fatigue Syndrome Show Characteristic Heart Rate Variability Profiles Reflecting Autonomic Dysregulations: Differentiation by Linear Discriminant Analysis.Sensors (Basel). 2023 Jun 4;23(11):5330. doi: 10.3390/s23115330. Sensors (Basel). 2023. PMID: 37300057 Free PMC article.
-
Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.Adv Exp Med Biol. 2024;1456:359-378. doi: 10.1007/978-981-97-4402-2_18. Adv Exp Med Biol. 2024. PMID: 39261438 Review.
-
Navigating the Intersection of Technology and Depression Precision Medicine.Adv Exp Med Biol. 2024;1456:401-426. doi: 10.1007/978-981-97-4402-2_20. Adv Exp Med Biol. 2024. PMID: 39261440 Review.
References
-
- Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization (2017). License: CC BY-NC-SA 3.0 IGO
-
- WHO. [Internet]. Geneva (2020) Fact sheet/depression [revised 30 January 2020, cited 12 April 2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
-
- GBD (2018) 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858. Erratum: Lancet. 2019;393(10190):e44 - DOI
-
- Wang J, Wu X, Lai W, Lai W, Long E, Zhang X, Li W et al (2017) Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open 7(8):e017173. https://doi.org/10.1136/bmjopen-2017-017173. - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources